REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPHW and the CUSIP is 76152G118. A total of 6 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $6,000 | -40.0% | 32,704 | -41.4% | 0.00% | – |
Q2 2022 | $10,000 | -61.5% | 55,839 | -45.8% | 0.00% | -100.0% |
Q1 2022 | $26,000 | -93.5% | 102,990 | -26.7% | 0.00% | -90.0% |
Q4 2021 | $398,000 | +598.2% | 140,462 | -1.6% | 0.01% | +400.0% |
Q3 2021 | $57,000 | -43.6% | 142,700 | -29.5% | 0.00% | -33.3% |
Q2 2021 | $101,000 | -12.2% | 202,293 | -19.1% | 0.00% | -25.0% |
Q1 2021 | $115,000 | -32.0% | 250,000 | 0.0% | 0.00% | -33.3% |
Q4 2020 | $169,000 | – | 250,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Arena Investors LP | 85,000 | $130,900 | 0.15% |
Walleye Capital LLC | 33,718 | $51,926 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Walleye Trading LLC | 25,727 | $39,620 | 0.00% |
B. Riley Wealth Advisors, Inc. | 11,101 | $17,096 | 0.00% |